Thrombocytopenia, Neonatal Alloimmune
2 clinical trials · Condition
◉ Watch Thrombocytopenia, Neonatal Alloimmune
| Record | Firm | Date |
|---|---|---|
| A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) (NCT06533098) | Janssen Research & Development, LLC | 2025-02-10 |
| A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) (NCT06449651) | Janssen Research & Development, LLC | 2024-11-11 |
Track Thrombocytopenia, Neonatal Alloimmune automatically
Every clearance here is in the API, with alerts when new ones post.